Eli Lilly and Company is a company in the U.S. stock market and it is a holding in 193 U.S.-traded ETFs. LLY has around 55.6M shares in the U.S. ETF market. The largest ETF holder of LLY is the SPDR S&P 500 ETF Trust (SPY), with approximately 9.18M shares. Investors may also find of interest that the ETF with the largest allocation to LLY stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 4.77%. On average, U.S. ETFs allocate 0.75% of LLY to their portfolios.

Additionally, LLY is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with LLY as a holding is the ProShares UltraPro S&P500 (UPRO), with a return of 37.82%.